Tuesday, March 29, 2011

Zhejiang Hisun Pharma Invests in U.S. Biotech Company

Zhejiang Hisun Pharmaceutical Co. has agreed to invest $5 million in Photolitec LLC, Buffalo, NY, which develops photosensitizing used to identify cancer through medical imaging technology. Zhejiang Hisun Pharmaceutical is listed on the Shanghai Stock Exchange and manufactures active pharmaceutical ingredients as well as pharmaceutical products.

No comments:

Post a Comment